Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC
(Vienna—August 7, 2022; 17:00 CEST) The use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can ...